BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22724413)

  • 1. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
    Kirshner HS
    Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
    Lalouschek W; Lang W; Müllner M;
    Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulants and non-cardioembolic stroke prevention.
    Schachter ME; Tran HA; Anand SS
    Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
    Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy for secondary prevention of stroke.
    Regesta G
    Clin Exp Hypertens; 2002; 24(7-8):555-62. PubMed ID: 12450231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary stroke prevention: review of clinical trials.
    Elkind MS
    Clin Cardiol; 2004 May; 27(5 Suppl 2):II25-35. PubMed ID: 15188933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
    Manaktala R; Kluger J
    J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient ischemic attacks: Part II. Treatment.
    Solenski NJ
    Am Fam Physician; 2004 Apr; 69(7):1681-8. PubMed ID: 15086040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin.
    Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Stroke; 2003 Jan; 34(1):234-5. PubMed ID: 12511782
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

  • 18. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.
    Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H;
    Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.